Academic Journal
WS01.5 A 2-part, phase 3 single-arm study to evaluate the safety and pharmacokinetics (PK) of lumacaftor/ivacaftor (LUM/IVA) combination therapy in patients (pts) aged 2 to 5 years with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation
| العنوان: | WS01.5 A 2-part, phase 3 single-arm study to evaluate the safety and pharmacokinetics (PK) of lumacaftor/ivacaftor (LUM/IVA) combination therapy in patients (pts) aged 2 to 5 years with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation |
|---|---|
| المؤلفون: | Mcnamara, J., Mccolley, S.A., Owen, C.A., Liu, F., Tian, S., Waltz, D., Marigowda, G., Sawicki, G.S. |
| المصدر: | Journal of Cystic Fibrosis ; volume 17, page S2-S3 ; ISSN 1569-1993 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2018 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s1569-1993(18)30123-1 |
| الاتاحة: | http://dx.doi.org/10.1016/s1569-1993(18)30123-1 https://api.elsevier.com/content/article/PII:S1569199318301231?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S1569199318301231?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| رقم الانضمام: | edsbas.8ADE5853 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s1569-1993(18)30123-1 |
|---|